Skip to content

China Medtech Radar

Menu
  • Home
  • Cardiology/Cardiovascular
  • Neurology/Neurovascular
  • Ophthalmology
  • Orthopedics
  • Robotics
  • News & Updates
  • Resources
  • Clinical
  • About
  • Login

NMPA Approves Domestic First Bio-Degradable Nasal Septal Cartilage Fixation System

June 4, 2026
On May 18, NMPA officially announced the marketing approval for the innovative “Nasal Septal Absorbable Fastener Fixation Device,” independently developed by Hefei Qihao Medical Technology...

Fishhawk® Disposable Thrombectomy Device Cleared for Deep Vein Thrombosis Is Approved by NMPA

May 15, 2026
On April 30, the Fishhawk® Disposable Thrombectomy Device of MicroPort Endovascular was approved by NMPA for commercialisation in China. Previously granted entry into the NMPA’s...

NMPA Approves Domestic Intracardiac Echocardiography (ICE) System, Advancing Precision Cardiac Intervention

May 15, 2026
On April 30, 2026, the Intracardiac Echocardiography (ICE) System and Disposable ICE Catheter—developed by Xi’an Huafeng Medical Technology Co., Ltd.—officially received market approval from the...

Precision Repair for High-Risk Patients: The NovoClasp Transcatheter Mitral Valve Clip System from Enlight Medical Is Approved by NMPA

May 1, 2026
The NovoClasp Transcatheter Mitral Valve Clip System is a breakthrough device that offers a life-changing, minimally invasive alternative for patients suffering from severe degenerative mitral...

ConBrella® Biodegradable PFO Occluder Approved by NMPA

May 1, 2026
ConBrella® Biodegradable Patent Foramen Ovale (PFO) Occluder System manufactured by Wuyou Tiaodong (WYTD) Medical Technology (Shenzhen) Co., Ltd. is officially approved by NMPA to launch...

Filling the Gap for High-Risk Patients: PIONEER TAVR® Transcatheter Aortic Valve System Approved by NMPA

March 11, 2026
Product Overview This innovative system from KOKA Lifesciences focuses on the precise clinical needs of elderly, high-risk patients suffering from symptomatic, severe aortic valve insufficiency...

Breakthrough in Precision Cardiac Access: RF-cross® Radiofrequency Transseptal Needle

March 11, 2026
Product Overview The RF-cross® is China’s first transseptal puncture system to integrate “Zero-Exchange” workflow, mechanical + radiofrequency (RF) dual technology, and steerable sheath compatibility. It...

Approval of the EasyEcho™ Intracardiac Echocardiography Imaging Catheter

February 1, 2026
On January 29, the National Medical Products Administration (NMPA) granted marketing approval to Shanghai MicroPort EP MedTech Co., Ltd. for the EasyEcho™ disposable intracardiac echocardiography...

SceneRay Receives NMPA Approval for World-First DBS System Targeting Opioid Addiction

January 2, 2026
In a landmark development for the global neuromodulation market, the National Medical Products Administration (NMPA) has officially granted marketing approval to SceneRay Medical’s Implantable Deep...

PerMedos’s Branched Intraoperative Aortic Stent System – A New Era for Stanford Type A Dissection Treatment Obtained NMPA Approval

December 2, 2025
The National Medical Products Administration (NMPA) of China approved the launch of the innovative product, the Helix Branched Intraoperative Aortic Stent System from PerMedos on...

Posts pagination

1 2 3

Trending


The China MedTech Edge: May 2026 Intelligence Briefing

More to Read


The New Competitive Edge: Clinical-Driven Innovation and the Rise of the Surgeon-Technologist in China’s Medtech Landscape

More to Read


China's $14M Bone 02 Glue: The 3-Minute Miracle Cure or Just an Adhesive Fantasy?

More to Read


High-Precision Technology and Global Strategy Driving China’s Next Wave of MedTech IPOs in 2025

More to Read


Beyond Price Cuts: VBP as a Driver for Innovation and Global Reach in Chinese Medtech

More to Read


Operated by IMPELINNO GmbH, China Medtech Radar is your news aggregator for Medtech innovation in China. Knowledge, Insights & Opportunities, that is what we are all about.

[email protected]
Weyermannsstrasse 36
Bern, 3008
Switzerland

Disclaimer

The information provided on this platform is aimed at providing knowledge and updates as of the date indicated. We make no representations or warranties regarding the accuracy, completeness, or reliability of the content obtained from publicly available information as indicated. By using this information, you acknowledge its potential limitations and assume all risks associated with its use. For more information, please see our full Disclaimer and Terms of Use.

← Back

Thank you for your response. ✨


© 2026 China Medtech Radar | WordPress Theme by Superb WordPress Themes
Back to Top ↑